Drug Allergy

Drug Allergy Guidelines (ACAAI/AAAAI)

Drug Allergy GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/88057

Contents of this Issue

Navigation

Page 15 of 25

Treatment Table 4. Groups of β-Lactam Antibiotics That Share Identical R1 Amoxicillin Ampicillin Cefadroxil Cefaclor Cefprozil Cephalexin Cefatrizine Cephradine -Group Side Chainsa Ceſtriaxone Cefoxitin Cefamandole Ceſtazidime Cefotaxime Cephaloridine Cefonicid Aztreonam Cefpodoxime Cephalothin Cefditoren Cephaloglycin Ceſtizoxime Loracarbef Cefmenoxime a Each column represents a group with identical R1 side chains. Table 5. Groups of β-Lactam Antibiotics That Share Identical R2 -Group Side Chainsa Cephalexin Cefotaxime Cefuroxime Cefotetan Cefadroxil Cephalothin Cefoxitin Cephradine Cephaloglycin Cephapirin a Each column represents a group with identical R2 Monobactams (aztreonam) Cefaclor Ceſtibuten Cefamandole Loracarbef Ceſtizoxime Cefmetazole Cefpiramide side chains. ÎAztreonam is less immunogenic than penicillin and cephalosporins, and clinical allergic reactions to aztreonam are less common than other β-lactam antibiotics. (C) ÎAztreonam does not cross-react with other β-lactams except for ceftazidime, with which it shares an identical R-group side chain. (B) Carbapenems ÎLimited data indicate lack of significant allergic cross-reactivity between penicillin and carbapenems. (B) > Penicillin skin test-negative patients may safely receive carbapenems. (C) > Give penicillin skin test-positive patients and patients with a history of penicillin allergy who do not undergo skin testing carbapenems via graded challenge. (C) Non–β-Lactam Antibiotics ÎAny non–β-lactam antibiotic has the potential of causing an IgE- mediated reaction, but these appear to occur less commonly than with β-lactam antibiotics. (C) ÎThere are no validated diagnostic tests for evaluation of IgE-mediated allergy to non–β-lactam antibiotics. (C) Evaluation of possible allergy to these antibiotics should be limited to situations when treatment with the drug is anticipated (rather than electively as for penicillin). (D) 14

Articles in this issue

Archives of this issue

view archives of Drug Allergy - Drug Allergy Guidelines (ACAAI/AAAAI)